|
|
||||||||
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
The polymorphic minor histocompatibility Ag HA-1 locus encodes two
peptides, HA-1H and HA-1R, with a single amino
acid difference. Whereas the immunogenicity of the HA-1R
allele has not yet been shown, the nonameric HA-1H peptide
induces HLA-A2-restricted cytotoxic T cells in vivo and in vitro. It is
not known whether the mHag HA-1H or HA-1R
associates with other HLA class I molecules. Therefore, the polymorphic
regions of both HA-1 alleles were analyzed to identify HLA class I
binding peptides that are properly processed by proteasomal
degradation. Peptide binding analyses were performed for all nonameric
HA-1H/R peptides for binding to nine HLA class I molecules
with >10% prevalence in the Caucasian population and for seven
nonameric/decameric HA-1H/R peptides predicted to bind to
HLA-A3, -B14, and -B60. Only the nonameric
KECVLH/RDDL and decameric
KECVLH/RDDLL peptides showed strong and stable
binding to HLA-B60. In vitro digestion of 29-aa-long HA-1 peptides by
purified 20S proteasomes revealed proper cleavage at the COOH termini
of both HLA-B60 binding HA-1H and HA-1R
peptides. In subsequent analyses, dendritic cells pulsed with the
nonameric HA-1R peptide did not induce CTLs that recognize
the natural HLA-B60/HA-1R ligand. In contrast, dendritic
cells pulsed with the nonameric HA-1H peptide induced
IFN-
-secreting T cells specific for the natural
HLA-B60/HA-1H ligand in three HLA-B60+
HA-1RR individuals, demonstrating the immunogenicity of the
HLA-B60/HA-1H ligand. In conclusion, this study shows a
novel HLA-B60-restricted T cell epitope of the minor histocompatibility
Ag HA-1 locus.
This article has been cited by other articles:
![]() |
E. Spierings, S. Gras, J.-B. Reiser, B. Mommaas, M. Almekinders, M. G. D. Kester, A. Chouquet, M. Le Gorrec, J. W. Drijfhout, F. Ossendorp, et al. Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele J. Immunol., April 15, 2009; 182(8): 4809 - 4816. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Tykodi, N. Fujii, N. Vigneron, S. M. Lu, J. K. Mito, M. X. Miranda, J. Chou, L. N. Voong, J. A. Thompson, B. M. Sandmaier, et al. C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients Clin. Cancer Res., August 15, 2008; 14(16): 5260 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawase, Y. Akatsuka, H. Torikai, S. Morishima, A. Oka, A. Tsujimura, M. Miyazaki, K. Tsujimura, K. Miyamura, S. Ogawa, et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen Blood, August 1, 2007; 110(3): 1055 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akatsuka, T. Nishida, E. Kondo, M. Miyazaki, H. Taji, H. Iida, K. Tsujimura, M. Yazaki, T. Naoe, Y. Morishima, et al. Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens J. Exp. Med., June 2, 2003; 197(11): 1489 - 1500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |